热暴露与川崎病之间的关联:一个时间分层的案例交叉研究
Nobutoshi Nawa1, Hisaaki Nishimura1, Kiyohide Fushimi2
1Department of Public Health, Institute of Science Tokyo, Tokyo, Japan.
Environmental research
|November 3, 2024
概括
每日平均高温与儿童因川崎病住院病例增加有关. 这项研究强调了极端高温与因这种儿童疾病住院住院的风险较高之间存在显著的关联.
科学领域:
- 环境健康 环境健康
- 儿科流行病学 儿科流行病学
- 气候学 气候学 气候学
背景情况:
- 关于每日平均温度和川崎病的全国性研究很少.
- 川崎病是儿科健康的一个重要问题,特别是在年幼的儿童中.
- 了解环境风险因素对于公共卫生干预至关重要.
研究的目的:
- 在日本调查环境温度和川崎病住院患者之间的关联.
- 量化与每日平均温度相关的川崎病住院的风险.
- 利用全国范围的行政索赔数据进行可靠的流行病学分析.
主要方法:
- 采用了时间分层的案例交叉研究设计.
- 分析了2011-2022年全国15岁以下患者住院的数据.
- 使用有条件的准斯回归和随机效应元分析,控制相对湿度.
主要成果:
- 共有48,784例Kawasaki病住院病例被记录,其中87.9%为5岁以下的儿童.
- 暴露于高每日平均温度显著增加了住院的风险.
- 极高的高温 (第99百分位) 与33%的更高风险有关 (RR 1.33,95% CI: 1.08,1.65).
结论:
- 每日平均温度升高与川崎病住院的风险增加有关.
- 这些发现表明,热暴露在川崎病的病因或恶化中可能发挥作用.
- 需要进一步的研究来阐明与高温和川崎病有关的潜在生物机制.
相关概念视频
Causality in Epidemiology
322
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
322
Relative Risk
118
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
118
Comparing the Survival Analysis of Two or More Groups
155
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
155
Criteria for Causality: Bradford Hill Criteria - I
213
The Bradford Hill criteria are a group of principles that provide a framework to determine a causal relationship between a specific factor and a disease. There are nine criteria that are pivotal in assessing causality in epidemiological studies. Here's a closer look at Strength, Consistency, Specificity, and Temporality criteria with definitions and examples:
213
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
121
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
121
Hazard Ratio
91
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
91


